Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (1) Gerhardt, Holger Prof. Dr. (1) Hübner, Norbert Prof. Dr. (1) Kammertöns, Thomas Dr. (5) Kunz, Severine Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (1) Uckert, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (4) (-) Blankenstein, Thomas Prof. Dr. (19) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) (-) 2000 (8) (-) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (3) 2015 (3) 2016 (4) (-) 2017 (6) 2018 (5) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) Biology of Malignant Lymphomas (8) Cancer Genetics and Cellular Stress Responses (1) Genetics and Genomics of Cardiovascular Diseases (1) Integrative Vascular Biology (1) Microenvironmental Regulation in Autoimmunity and Cancer (2) (-) Molecular Immunology and Gene Therapy (19) Translational Bioinformatics (1) Translational Tumorimmunology (1) 19 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Molecular Immunology and Gene Therapy200020012017 Sort: Result score Newest to oldest Oldest to newest January 01, 2001 / Nat Med Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay C. Becker H. Pohla B. Frankenberger T. Schueler M. Assenmacher D.J. Schendel T. Blankenstein December 03, 2001 / J Exp Med Tumor rejection by disturbing tumor stroma cell interactions S. Ibe Z.H. Qin T. Schueler S. Preiss T. Blankenstein December 17, 2001 / J Exp Med Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8+ T cells T. Schueler T. Kammertoens S. Preiss P. Debs N. Noben-Trauth T. Blankenstein February 01, 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein January 01, 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein June 01, 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein May 01, 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto May 01, 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel October 01, 2000 / Tissue Antigens Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber December 01, 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 2001 / Nat Med Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay C. Becker H. Pohla B. Frankenberger T. Schueler M. Assenmacher D.J. Schendel T. Blankenstein
December 03, 2001 / J Exp Med Tumor rejection by disturbing tumor stroma cell interactions S. Ibe Z.H. Qin T. Schueler S. Preiss T. Blankenstein
December 17, 2001 / J Exp Med Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8+ T cells T. Schueler T. Kammertoens S. Preiss P. Debs N. Noben-Trauth T. Blankenstein
February 01, 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein
January 01, 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein
June 01, 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein
May 01, 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto
May 01, 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel
October 01, 2000 / Tissue Antigens Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber
December 01, 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein